Drug Companies Worry About New “Totality of Evidence” Standard: Is It an About–Face From the FDA on Off-Label Promotion?

類似資料

• Hospitals Worry About New FDA Proposal For Medical Devices: Technical Complexities of Labels Could Compromise Utility
  著者:: Barlas, Stephen
  出版事項: (2013)
• FDA may allow drug and device companies to promote “off-label” uses
  著者:: Tanne, Janice Hopkins
  出版事項: (2007)
• FDA Wants Companies to Simplify Drug Packaging, Naming, and Labeling To Reduce Medication Errors
  著者:: Barlas, Stephen
  出版事項: (2010)
• FDA to Reassess Policies on Unsolicited Requests for Off-Label Information: Differentiating ‘Scientific Exchange’ From ‘Promotion’ Is Complicated
  著者:: Barlas, Stephen
  出版事項: (2012)
• Possibility of FDA Regulation of Health Information Technology Looms Large: Pharmacies and Their Vendors Worry About Quality
  著者:: Barlas, Stephen
  出版事項: (2013)